Untangling determinants of enhanced health and lifespan through a multi-omics approach in mice
And due to better-than-expected growth in tirzepatide drugs, which blew past Wall Street's expectations, Lilly's management raised its full-year 2026 revenue guidance to between $82.2 billion and $85 billion, up $2 billion from previous expectations
A., Whitington, P
The connection between lizard venom and GLP-1 medications represents one of the most remarkable examples of biomimicry in modern pharmacology
If approved by control agencies, CagriSema would offer people with obesity a highly effective, non-surgical option for achieving large, sustained weight loss
Koole C, Wootten D, Simms J, Valant C, Sridhar R, Woodman OL, et al